New Antibiotics for Resistant Infections: What Happens After Approval?

Ann Intern Med. 2024 May;177(5):674-675. doi: 10.7326/M24-0192. Epub 2024 Apr 19.

Authors

Jessica Howard-Anderson¹, Helen W Boucher²

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
² Tufts University School of Medicine and Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts.

PMID: 38639541
DOI: 10.7326/M24-0192

No abstract available

MeSH terms

Anti-Bacterial Agents* / therapeutic use
Drug Approval*
Drug Resistance, Bacterial
Humans
United States
United States Food and Drug Administration*